ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 126 filers reported holding ANAPTYSBIO INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,268,945 | -11.7% | 70,654 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,437,102 | -6.5% | 70,654 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,537,431 | +63879.7% | 70,654 | -8.9% | 0.00% | -50.0% |
| Q4 2022 | $2,403 | -99.9% | 77,550 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $1,978,000 | +25.7% | 77,550 | +0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,574,000 | -6.3% | 77,540 | +14.2% | 0.00% | 0.0% |
| Q1 2022 | $1,680,000 | -18.6% | 67,889 | +14.3% | 0.00% | 0.0% |
| Q4 2021 | $2,065,000 | +65.5% | 59,421 | +29.1% | 0.00% | 0.0% |
| Q3 2021 | $1,248,000 | – | 46,019 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |